Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

ELS vs NUVB vs SUI vs KYMR vs ARVN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ELS
Equity LifeStyle Properties, Inc.

REIT - Residential

Real EstateNYSE • US
Market Cap$12.27B
5Y Perf.-4.5%
NUVB
Nuvation Bio Inc.

Biotechnology

HealthcareNYSE • US
Market Cap$1.67B
5Y Perf.-51.8%
SUI
Sun Communities, Inc.

REIT - Residential

Real EstateNYSE • US
Market Cap$15.54B
5Y Perf.-15.4%
KYMR
Kymera Therapeutics, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$6.91B
5Y Perf.+165.3%
ARVN
Arvinas, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$652M
5Y Perf.-60.7%

ELS vs NUVB vs SUI vs KYMR vs ARVN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ELS logoELS
NUVB logoNUVB
SUI logoSUI
KYMR logoKYMR
ARVN logoARVN
IndustryREIT - ResidentialBiotechnologyREIT - ResidentialBiotechnologyBiotechnology
Market Cap$12.27B$1.67B$15.54B$6.91B$652M
Revenue (TTM)$1.53B$143M$2.32B$51M$263M
Net Income (TTM)$387M$-146M$1.55B$-315M$-81M
Gross Margin37.6%91.6%51.9%33.2%99.5%
Operating Margin33.8%-105.0%24.0%-7.0%-44.0%
Forward P/E31.1x47.1x
Total Debt$3.37B$10M$1.83B$82M$9M
Cash & Equiv.$26M$164M$636M$357M$143M

ELS vs NUVB vs SUI vs KYMR vs ARVNLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ELS
NUVB
SUI
KYMR
ARVN
StockAug 20May 26Return
Equity LifeStyle Pr… (ELS)10095.5-4.5%
Nuvation Bio Inc. (NUVB)10048.2-51.8%
Sun Communities, In… (SUI)10084.6-15.4%
Kymera Therapeutics… (KYMR)100265.3+165.3%
Arvinas, Inc. (ARVN)10039.3-60.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: ELS vs NUVB vs SUI vs KYMR vs ARVN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SUI leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Equity LifeStyle Properties, Inc. is the stronger pick specifically for capital preservation and lower volatility. NUVB and KYMR also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ELS
Equity LifeStyle Properties, Inc.
The Real Estate Income Play

ELS is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 12 yrs, beta 0.02, yield 3.2%
  • Beta 0.02 vs NUVB's 2.04
Best for: income & stability
NUVB
Nuvation Bio Inc.
The Growth Play

NUVB ranks third and is worth considering specifically for growth exposure.

  • Rev growth 7.0%, EPS growth 71.6%
  • 7.0% revenue growth vs SUI's -27.9%
Best for: growth exposure
SUI
Sun Communities, Inc.
The Real Estate Income Play

SUI carries the broadest edge in this set and is the clearest fit for valuation efficiency and defensive.

  • PEG 0.91 vs ELS's 3.01
  • Beta 0.26, yield 6.6%, current ratio 0.38x
  • Better valuation composite
  • 66.9% margin vs KYMR's -6.1%
Best for: valuation efficiency and defensive
KYMR
Kymera Therapeutics, Inc.
The Long-Run Compounder

KYMR is the clearest fit if your priority is long-term compounding.

  • 154.4% 10Y total return vs SUI's 123.4%
  • +190.7% vs ELS's +1.6%
Best for: long-term compounding
ARVN
Arvinas, Inc.
The Defensive Pick

ARVN is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.15, Low D/E 2.0%, current ratio 4.92x
Best for: sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthNUVB logoNUVB7.0% revenue growth vs SUI's -27.9%
ValueSUI logoSUIBetter valuation composite
Quality / MarginsSUI logoSUI66.9% margin vs KYMR's -6.1%
Stability / SafetyELS logoELSBeta 0.02 vs NUVB's 2.04
DividendsSUI logoSUI6.6% yield, 9-year raise streak, vs ELS's 3.2%, (3 stocks pay no dividend)
Momentum (1Y)KYMR logoKYMR+190.7% vs ELS's +1.6%
Efficiency (ROA)SUI logoSUI12.2% ROA vs NUVB's -23.8%, ROIC 3.2% vs -54.3%

ELS vs NUVB vs SUI vs KYMR vs ARVN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ELSEquity LifeStyle Properties, Inc.
FY 2025
Home Sales, Brokered Resales And Ancillary Services
100.0%$86M
NUVBNuvation Bio Inc.
FY 2025
License
60.8%$38M
Product
39.2%$25M
SUISun Communities, Inc.
FY 2025
MH
50.9%$1.1B
RV
29.9%$669M
UK Segment
19.1%$427M
KYMRKymera Therapeutics, Inc.

Segment breakdown not available.

ARVNArvinas, Inc.
FY 2025
License
100.0%$130M

ELS vs NUVB vs SUI vs KYMR vs ARVN — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLELSLAGGINGARVN

Income & Cash Flow (Last 12 Months)

Evenly matched — NUVB and SUI each lead in 2 of 6 comparable metrics.

SUI is the larger business by revenue, generating $2.3B annually — 45.2x KYMR's $51M. SUI is the more profitable business, keeping 66.9% of every revenue dollar as net income compared to KYMR's -6.1%. On growth, NUVB holds the edge at +26.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.SUI logoSUISun Communities, …KYMR logoKYMRKymera Therapeuti…ARVN logoARVNArvinas, Inc.
RevenueTrailing 12 months$1.5B$143M$2.3B$51M$263M
EBITDAEarnings before interest/tax$727M-$145M$1.1B-$352M-$111M
Net IncomeAfter-tax profit$387M-$146M$1.6B-$315M-$81M
Free Cash FlowCash after capex$334M-$126M$884M-$244M-$276M
Gross MarginGross profit ÷ Revenue+37.6%+91.6%+51.9%+33.2%+99.5%
Operating MarginEBIT ÷ Revenue+33.8%-105.0%+24.0%-7.0%-44.0%
Net MarginNet income ÷ Revenue+25.2%-102.1%+66.9%-6.1%-30.8%
FCF MarginFCF ÷ Revenue+21.8%-88.1%+38.0%-4.7%-105.0%
Rev. Growth (YoY)Latest quarter vs prior year+22.4%+26.0%+8.4%+55.5%-84.0%
EPS Growth (YoY)Latest quarter vs prior year-8.3%+106.3%+79.4%+13.4%-65.1%
Evenly matched — NUVB and SUI each lead in 2 of 6 comparable metrics.

Valuation Metrics

SUI leads this category, winning 3 of 7 comparable metrics.

At 11.6x trailing earnings, SUI trades at a 65% valuation discount to ELS's 32.8x P/E. Adjusting for growth (PEG ratio), SUI offers better value at 0.22x vs ELS's 3.17x — a lower PEG means you pay less per unit of expected earnings growth.

MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.SUI logoSUISun Communities, …KYMR logoKYMRKymera Therapeuti…ARVN logoARVNArvinas, Inc.
Market CapShares × price$12.3B$1.7B$15.5B$6.9B$652M
Enterprise ValueMkt cap + debt − cash$15.6B$1.5B$16.7B$6.6B$517M
Trailing P/EPrice ÷ TTM EPS32.79x-8.03x11.63x-22.93x-7.96x
Forward P/EPrice ÷ next-FY EPS est.31.11x47.12x
PEG RatioP/E ÷ EPS growth rate3.17x0.22x
EV / EBITDAEnterprise value multiple21.48x16.90x
Price / SalesMarket cap ÷ Revenue8.01x26.61x6.74x176.26x2.48x
Price / BookPrice ÷ Book value/share6.98x5.38x2.19x4.52x1.52x
Price / FCFMarket cap ÷ FCF36.74x17.98x
SUI leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

ELS leads this category, winning 4 of 9 comparable metrics.

SUI delivers a 21.6% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-44 for NUVB. ARVN carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to ELS's 1.85x. On the Piotroski fundamental quality scale (0–9), ELS scores 6/9 vs ARVN's 4/9, reflecting solid financial health.

MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.SUI logoSUISun Communities, …KYMR logoKYMRKymera Therapeuti…ARVN logoARVNArvinas, Inc.
ROE (TTM)Return on equity+21.3%-44.1%+21.6%-25.0%-14.3%
ROA (TTM)Return on assets+6.8%-23.8%+12.2%-22.3%-9.3%
ROICReturn on invested capital+7.6%-54.3%+3.2%-24.9%-22.4%
ROCEReturn on capital employed+9.7%-42.8%+4.0%-27.2%-16.0%
Piotroski ScoreFundamental quality 0–964644
Debt / EquityFinancial leverage1.85x0.03x0.25x0.05x0.02x
Net DebtTotal debt minus cash$3.3B-$154M$1.2B-$275M-$134M
Cash & Equiv.Liquid assets$26M$164M$636M$357M$143M
Total DebtShort + long-term debt$3.4B$10M$1.8B$82M$9M
Interest CoverageEBIT ÷ Interest expense2.98x-162.11x0.78x-2119.53x
ELS leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

KYMR leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in KYMR five years ago would be worth $19,212 today (with dividends reinvested), compared to $1,601 for ARVN. Over the past 12 months, KYMR leads with a +190.7% total return vs ELS's +1.6%. The 3-year compound annual growth rate (CAGR) favors KYMR at 45.0% vs ARVN's -25.5% — a key indicator of consistent wealth creation.

MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.SUI logoSUISun Communities, …KYMR logoKYMRKymera Therapeuti…ARVN logoARVNArvinas, Inc.
YTD ReturnYear-to-date+6.8%-43.8%+4.1%+16.3%-11.2%
1-Year ReturnPast 12 months+1.6%+136.3%+7.8%+190.7%+52.8%
3-Year ReturnCumulative with dividends+0.2%+197.5%+4.5%+205.1%-58.7%
5-Year ReturnCumulative with dividends+3.5%-58.3%-10.2%+92.1%-84.0%
10-Year ReturnCumulative with dividends+106.7%-51.8%+123.4%+154.4%-36.5%
CAGR (3Y)Annualised 3-year return+0.1%+43.8%+1.5%+45.0%-25.5%
KYMR leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

ELS leads this category, winning 2 of 2 comparable metrics.

ELS is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than NUVB's 2.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ELS currently trades 91.7% from its 52-week high vs NUVB's 49.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.SUI logoSUISun Communities, …KYMR logoKYMRKymera Therapeuti…ARVN logoARVNArvinas, Inc.
Beta (5Y)Sensitivity to S&P 5000.02x2.04x0.26x1.15x1.15x
52-Week HighHighest price in past year$69.00$9.75$137.85$103.00$14.51
52-Week LowLowest price in past year$58.15$1.57$115.53$28.06$5.90
% of 52W HighCurrent price vs 52-week peak+91.7%+49.4%+91.5%+82.2%+70.2%
RSI (14)Momentum oscillator 0–10047.559.142.254.142.6
Avg Volume (50D)Average daily shares traded1.7M4.3M792K602K808K
ELS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — ELS and SUI each lead in 1 of 2 comparable metrics.

Analyst consensus: ELS as "Buy", NUVB as "Buy", SUI as "Buy", KYMR as "Buy", ARVN as "Buy". Consensus price targets imply 157.3% upside for NUVB (target: $12) vs 11.3% for SUI (target: $140). For income investors, SUI offers the higher dividend yield at 6.63% vs ELS's 3.20%.

MetricELS logoELSEquity LifeStyle …NUVB logoNUVBNuvation Bio Inc.SUI logoSUISun Communities, …KYMR logoKYMRKymera Therapeuti…ARVN logoARVNArvinas, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$70.57$12.40$140.29$117.06$13.00
# AnalystsCovering analysts219202626
Dividend YieldAnnual dividend ÷ price+3.2%+6.6%
Dividend StreakConsecutive years of raises129
Dividend / ShareAnnual DPS$2.02$8.36
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+3.5%0.0%+14.1%
Evenly matched — ELS and SUI each lead in 1 of 2 comparable metrics.
Key Takeaway

ELS leads in 2 of 6 categories (Profitability & Efficiency, Risk & Volatility). SUI leads in 1 (Valuation Metrics). 2 tied.

Best OverallEquity LifeStyle Properties… (ELS)Leads 2 of 6 categories
Loading custom metrics...

ELS vs NUVB vs SUI vs KYMR vs ARVN: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ELS or NUVB or SUI or KYMR or ARVN a better buy right now?

For growth investors, Nuvation Bio Inc.

(NUVB) is the stronger pick with 699. 0% revenue growth year-over-year, versus -27. 9% for Sun Communities, Inc. (SUI). Sun Communities, Inc. (SUI) offers the better valuation at 11. 6x trailing P/E (47. 1x forward), making it the more compelling value choice. Analysts rate Equity LifeStyle Properties, Inc. (ELS) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ELS or NUVB or SUI or KYMR or ARVN?

On trailing P/E, Sun Communities, Inc.

(SUI) is the cheapest at 11. 6x versus Equity LifeStyle Properties, Inc. at 32. 8x. On forward P/E, Equity LifeStyle Properties, Inc. is actually cheaper at 31. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Sun Communities, Inc. wins at 0. 91x versus Equity LifeStyle Properties, Inc. 's 3. 01x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — ELS or NUVB or SUI or KYMR or ARVN?

Over the past 5 years, Kymera Therapeutics, Inc.

(KYMR) delivered a total return of +92. 1%, compared to -84. 0% for Arvinas, Inc. (ARVN). Over 10 years, the gap is even starker: KYMR returned +154. 4% versus NUVB's -51. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ELS or NUVB or SUI or KYMR or ARVN?

By beta (market sensitivity over 5 years), Equity LifeStyle Properties, Inc.

(ELS) is the lower-risk stock at 0. 02β versus Nuvation Bio Inc. 's 2. 04β — meaning NUVB is approximately 9648% more volatile than ELS relative to the S&P 500. On balance sheet safety, Arvinas, Inc. (ARVN) carries a lower debt/equity ratio of 2% versus 185% for Equity LifeStyle Properties, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ELS or NUVB or SUI or KYMR or ARVN?

By revenue growth (latest reported year), Nuvation Bio Inc.

(NUVB) is pulling ahead at 699. 0% versus -27. 9% for Sun Communities, Inc. (SUI). On earnings-per-share growth, the picture is similar: Sun Communities, Inc. grew EPS 1427% year-over-year, compared to -23. 8% for Kymera Therapeutics, Inc.. Over a 3-year CAGR, ARVN leads at 26. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ELS or NUVB or SUI or KYMR or ARVN?

Sun Communities, Inc.

(SUI) is the more profitable company, earning 59. 6% net margin versus -794. 4% for Kymera Therapeutics, Inc. — meaning it keeps 59. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ELS leads at 33. 8% versus -891. 3% for KYMR. At the gross margin level — before operating expenses — KYMR leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ELS or NUVB or SUI or KYMR or ARVN more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Sun Communities, Inc. (SUI) is the more undervalued stock at a PEG of 0. 91x versus Equity LifeStyle Properties, Inc. 's 3. 01x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Equity LifeStyle Properties, Inc. (ELS) trades at 31. 1x forward P/E versus 47. 1x for Sun Communities, Inc. — 16. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NUVB: 157. 3% to $12. 40.

08

Which pays a better dividend — ELS or NUVB or SUI or KYMR or ARVN?

In this comparison, SUI (6.

6% yield), ELS (3. 2% yield) pay a dividend. NUVB, KYMR, ARVN do not pay a meaningful dividend and should not be held primarily for income.

09

Is ELS or NUVB or SUI or KYMR or ARVN better for a retirement portfolio?

For long-horizon retirement investors, Equity LifeStyle Properties, Inc.

(ELS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 02), 3. 2% yield, +106. 7% 10Y return). Nuvation Bio Inc. (NUVB) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ELS: +106. 7%, NUVB: -51. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ELS and NUVB and SUI and KYMR and ARVN?

These companies operate in different sectors (ELS (Real Estate) and NUVB (Healthcare) and SUI (Real Estate) and KYMR (Healthcare) and ARVN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ELS is a mid-cap income-oriented stock; NUVB is a small-cap high-growth stock; SUI is a mid-cap deep-value stock; KYMR is a small-cap quality compounder stock; ARVN is a small-cap quality compounder stock. ELS, SUI pay a dividend while NUVB, KYMR, ARVN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ELS

High-Growth Quality Leader

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 15%
Run This Screen
Stocks Like

NUVB

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 1299%
  • Gross Margin > 54%
Run This Screen
Stocks Like

SUI

Dividend Mega-Cap Quality

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 40%
Run This Screen
Stocks Like

KYMR

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 27%
  • Gross Margin > 19%
Run This Screen
Stocks Like

ARVN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 59%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ELS and NUVB and SUI and KYMR and ARVN on the metrics below

Revenue Growth>
%
(ELS: 22.4% · NUVB: 2598.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.